Tredje AP fonden Buys 19,075 Shares of McKesson Co. (NYSE:MCK)

Tredje AP fonden lifted its stake in shares of McKesson Co. (NYSE:MCK) by 19.6% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 116,575 shares of the company’s stock after acquiring an additional 19,075 shares during the quarter. Tredje AP fonden owned about 0.09% of McKesson worth $66,437,000 as of its most recent filing with the SEC.

Other large investors also recently made changes to their positions in the company. MidAtlantic Capital Management Inc. bought a new stake in shares of McKesson during the 3rd quarter worth about $29,000. RPg Family Wealth Advisory LLC bought a new stake in McKesson during the 3rd quarter valued at approximately $31,000. Synergy Asset Management LLC acquired a new position in McKesson in the 4th quarter valued at approximately $32,000. Crews Bank & Trust acquired a new position in McKesson in the 4th quarter valued at approximately $33,000. Finally, Creative Capital Management Investments LLC acquired a new position in McKesson in the 4th quarter valued at approximately $44,000. Institutional investors own 85.07% of the company’s stock.

Insider Transactions at McKesson

In related news, CEO Brian S. Tyler sold 8,961 shares of the firm’s stock in a transaction on Friday, February 21st. The stock was sold at an average price of $597.99, for a total transaction of $5,358,588.39. Following the sale, the chief executive officer now owns 60,664 shares of the company’s stock, valued at approximately $36,276,465.36. This trade represents a 12.87 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Leann B. Smith sold 188 shares of the firm’s stock in a transaction on Wednesday, February 12th. The stock was sold at an average price of $609.59, for a total value of $114,602.92. Following the sale, the executive vice president now directly owns 1,051 shares in the company, valued at $640,679.09. The trade was a 15.17 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 18,689 shares of company stock worth $11,187,351 in the last three months. Insiders own 0.11% of the company’s stock.

Analyst Ratings Changes

MCK has been the subject of several recent research reports. Citigroup cut their price target on McKesson from $713.00 to $677.00 and set a “buy” rating for the company in a report on Friday, January 10th. Mizuho began coverage on McKesson in a report on Wednesday, December 4th. They issued a “neutral” rating and a $630.00 target price for the company. Wells Fargo & Company increased their target price on McKesson from $535.00 to $641.00 and gave the stock an “equal weight” rating in a report on Friday, December 13th. Morgan Stanley increased their target price on McKesson from $612.00 to $642.00 and gave the stock an “overweight” rating in a report on Tuesday, December 17th. Finally, Evercore ISI increased their price target on McKesson from $650.00 to $675.00 and gave the stock an “outperform” rating in a research report on Thursday, February 6th. Two analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $645.79.

McKesson Stock Performance

Shares of MCK opened at $640.93 on Thursday. The firm has a market capitalization of $80.32 billion, a price-to-earnings ratio of 29.35, a PEG ratio of 1.29 and a beta of 0.52. The business’s fifty day moving average price is $605.54 and its two-hundred day moving average price is $569.47. McKesson Co. has a 52 week low of $464.42 and a 52 week high of $663.61.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. As a group, research analysts forecast that McKesson Co. will post 32.77 EPS for the current year.

McKesson Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 1st. Stockholders of record on Monday, March 3rd will be given a $0.71 dividend. The ex-dividend date of this dividend is Monday, March 3rd. This represents a $2.84 annualized dividend and a dividend yield of 0.44%. McKesson’s dividend payout ratio is currently 13.00%.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.